Clinical trial
TOLER-ENT Study: A Study to Investigate the Tolerance of the High Energy, High Protein Formula Sondalis® HP 2 kcal
NCT05429853 is registered in ClinicalTrials.gov with Société des Produits Nestlé (SPN) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TOLER-ENT Study: A Study to Investigate the Tolerance of the High Energy, High Protein Formula Sondalis® HP 2 kcal
- Lead sponsor
- Société des Produits Nestlé (SPN)
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 8, 2022
- Completion date
- May 28, 2024
- Enrollment
- 17 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.